Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing mice.
Minimally invasive diagnosis and treatment of endometrial cancer after LeFort colpocleisis.
See All 2 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing mice.
McRae Page S, Henchey E, Chen X, Schneider S, Emrick T. Efficacy of polyMPC-DOX prodrugs in 4T1 tumor-bearing mice. Mol Pharm. 2014 May 05; 11(5):1715-20.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Doxorubicin
Female
Mammary Neoplasms, Experimental
Mice
Mice, Inbred BALB C
Polymers
Prodrugs
Xenograft Model Antitumor Assays
authors with profiles
Todd S Emrick PhD
Sallie Smith Schneider PhD